Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles

There are currently no approved therapeutics or vaccines to treat or protect against the severe hemorrhagic fever and death caused by Ebola virus (EBOV). Ebola virus-like particles (EBOV VLPs) consisting of the matrix protein VP40, the glycoprotein (GP), and the nucleoprotein (NP) are highly immunog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Schweneker, Marc, Laimbacher, Andrea S., Zimmer, Gert, Wagner, Susanne, Schraner, Elisabeth M., Wolferstätter, Michael, Klingenberg, Marieken, Dirmeier, Ulrike, Steigerwald, Robin, Lauterbach, Henning, Hochrein, Hubertus, Chaplin, Paul, Suter, Mark, Hausmann, Jürgen
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5432887/
https://ncbi.nlm.nih.gov/pubmed/28331098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00343-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars